Suppr超能文献

端粒结合蛋白(RAP1和POT1)在肾细胞癌中的表达及其与临床病理参数的相关性

Expression of Telomere Binding Proteins (RAP1 and POT1) in Renal Cell Carcinoma and Their Correlation with Clinicopathological Parameters.

作者信息

Pal Deeksha, Singh Shrawan Kumar, Kakkar Nandita, Prasad Rajendra

机构信息

Department of Biochemistry, PGIMER, Chandigarh, India.

Department of Urology, University of Louisville, Louisville, KY USA.

出版信息

Indian J Clin Biochem. 2017 Jul;32(3):301-305. doi: 10.1007/s12291-016-0611-8. Epub 2016 Sep 3.

Abstract

Telomere stability is indispensable for continuous proliferation of cells. Telomere structure is maintained by group of six proteins termed as shelterin. RAP1 and POT1 proteins are significant members of shelterin complex. Expression of RAP1 and POT1 are crucial for telomere maintenance and hence uncontrolled division of cells. Notably, expression of RAP1 and POT1 is unknown in renal cell carcinoma (RCC). In view of these facts, the present study was initiated to investigate the expression of RAP1 and POT1 in RCC and their relationships with clinicopathological features. In total 65 histopathologically confirmed RCC cases and their adjacent normal renal parenchyma were analyzed for gene expression. The mRNA expression of telomere binding proteins RAP1 and POT1 were measured using RT-PCR. Expression of RAP1 was observed to be significantly increased in tumour tissues as compared to corresponding normal renal tissues ( = 0.004). The gene expression of RAP1 was documented to be related to grades of RCC ( = 0.002) and subtypes of RCC ( = 0.01). Although, POT1 expression was up-regulated in RCC tissue, however it was not statistically significant. Also, POT1 expression was not related to grades, stages and subtypes of RCC. This is the first study which shows correlation RAP1 with grades and subtypes of RCC.

摘要

端粒稳定性对于细胞的持续增殖不可或缺。端粒结构由一组被称为保护素的六种蛋白质维持。RAP1和POT1蛋白是保护素复合体的重要成员。RAP1和POT1的表达对于端粒维持以及细胞的无控制分裂至关重要。值得注意的是,肾细胞癌(RCC)中RAP1和POT1的表达情况尚不清楚。鉴于这些事实,本研究旨在调查RAP1和POT1在肾细胞癌中的表达及其与临床病理特征的关系。总共对65例经组织病理学确诊的肾细胞癌病例及其相邻的正常肾实质进行了基因表达分析。使用逆转录聚合酶链反应(RT-PCR)检测端粒结合蛋白RAP1和POT1的mRNA表达。与相应的正常肾组织相比,肿瘤组织中RAP1的表达明显增加(P = 0.004)。RAP1的基因表达与肾细胞癌的分级(P = 0.002)和亚型(P = 0.01)相关。虽然POT1在肾细胞癌组织中的表达上调,但无统计学意义。此外,POT1的表达与肾细胞癌的分级、分期和亚型无关。这是第一项显示RAP1与肾细胞癌分级和亚型相关的研究。

相似文献

6
G-quadruplex-mediated regulation of telomere binding protein POT1 gene expression.G-四链体介导的端粒结合蛋白POT1基因表达调控。
Biochim Biophys Acta. 2014 Jul;1840(7):2222-33. doi: 10.1016/j.bbagen.2014.03.001. Epub 2014 Mar 12.
9
Telomere length variation and expression analysis of shelterin complex genes during gallbladder carcinogenesis.
J Cancer Res Ther. 2017 Apr-Jun;13(2):235-239. doi: 10.4103/0973-1482.184512.
10
[mRNA expression of telomere protection protein TIN2 and POT1 in bone marrow of patients with myelodysplastic syndrome].
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Feb;21(1):110-5. doi: 10.7534/j.issn.1009-2137.2013.01.023.

引用本文的文献

1
Decoding 's Role in Yeast mRNA Splicing.解码在酵母mRNA剪接中的作用。
bioRxiv. 2025 Apr 8:2025.04.04.647307. doi: 10.1101/2025.04.04.647307.
6
Role of POT1 in Human Cancer.POT1在人类癌症中的作用。
Cancers (Basel). 2020 Sep 24;12(10):2739. doi: 10.3390/cancers12102739.
8
Telomere-related Markers for Cancer.端粒相关标志物在癌症中的应用。
Curr Top Med Chem. 2020;20(6):410-432. doi: 10.2174/1568026620666200106145340.

本文引用的文献

3
Prevalence of telomerase activity in human cancer.端粒酶活性在人类癌症中的流行率。
J Formos Med Assoc. 2011 May;110(5):275-89. doi: 10.1016/S0929-6646(11)60043-0.
4
5
Epidemiology and risk factors for kidney cancer.肾癌的流行病学和危险因素。
Nat Rev Urol. 2010 May;7(5):245-57. doi: 10.1038/nrurol.2010.46.
7
Telomeres: protecting chromosomes against genome instability.端粒:保护染色体免受基因组不稳定的影响。
Nat Rev Mol Cell Biol. 2010 Mar;11(3):171-81. doi: 10.1038/nrm2848. Epub 2010 Feb 3.
8
How shelterin protects mammalian telomeres.端粒保护蛋白复合体如何保护哺乳动物的端粒。
Annu Rev Genet. 2008;42:301-34. doi: 10.1146/annurev.genet.41.110306.130350.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验